 James Maloney
Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 2 | 2023 | 196 | 0.850 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2016 | 496 | 0.850 |
Why?
| | Cricoid Cartilage | 1 | 2023 | 15 | 0.840 |
Why?
| | Pulmonary Eosinophilia | 1 | 2021 | 25 | 0.730 |
Why?
| | Vaping | 1 | 2021 | 45 | 0.680 |
Why?
| | Lung Injury | 1 | 2021 | 192 | 0.620 |
Why?
| | Marijuana Smoking | 1 | 2021 | 224 | 0.570 |
Why?
| | Apyrase | 1 | 2017 | 14 | 0.560 |
Why?
| | Transforming Growth Factor beta1 | 2 | 2020 | 153 | 0.540 |
Why?
| | Serum | 1 | 2016 | 57 | 0.520 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 270 | 0.510 |
Why?
| | Polymorphism, Single Nucleotide | 9 | 2023 | 1880 | 0.500 |
Why?
| | Plasma | 1 | 2016 | 181 | 0.480 |
Why?
| | Antigens, CD | 1 | 2017 | 440 | 0.470 |
Why?
| | Acute Lung Injury | 4 | 2020 | 268 | 0.460 |
Why?
| | Venous Thromboembolism | 1 | 2017 | 230 | 0.440 |
Why?
| | Blood Platelets | 1 | 2016 | 326 | 0.430 |
Why?
| | Hypertension, Pulmonary | 4 | 2020 | 1736 | 0.430 |
Why?
| | Endothelial Cells | 2 | 2015 | 677 | 0.420 |
Why?
| | Pulmonary Alveoli | 1 | 2015 | 372 | 0.410 |
Why?
| | Genetic Predisposition to Disease | 5 | 2017 | 2090 | 0.400 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 24 | 0.390 |
Why?
| | Sepsis | 7 | 2023 | 507 | 0.370 |
Why?
| | Cytokines | 3 | 2023 | 1824 | 0.360 |
Why?
| | Mutation, Missense | 1 | 2011 | 294 | 0.340 |
Why?
| | Lung | 2 | 2021 | 3521 | 0.320 |
Why?
| | Thrombospondin 1 | 2 | 2020 | 19 | 0.320 |
Why?
| | Transforming Growth Factor beta | 3 | 2017 | 445 | 0.300 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2007 | 41 | 0.280 |
Why?
| | Cystic Fibrosis | 1 | 2016 | 955 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2023 | 1128 | 0.270 |
Why?
| | Hypoxia | 3 | 2020 | 956 | 0.250 |
Why?
| | Thrombospondins | 1 | 2004 | 4 | 0.230 |
Why?
| | Expressed Sequence Tags | 1 | 2004 | 38 | 0.230 |
Why?
| | Databases, Nucleic Acid | 1 | 2004 | 31 | 0.230 |
Why?
| | Forms and Records Control | 1 | 2004 | 21 | 0.230 |
Why?
| | Altitude Sickness | 1 | 2005 | 170 | 0.220 |
Why?
| | Surgical Instruments | 1 | 2023 | 48 | 0.210 |
Why?
| | Biopsy | 2 | 2021 | 1024 | 0.200 |
Why?
| | Hirudins | 1 | 2002 | 46 | 0.200 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 14 | 0.200 |
Why?
| | Cadaver | 1 | 2023 | 298 | 0.190 |
Why?
| | Diagnosis, Differential | 2 | 2021 | 1331 | 0.190 |
Why?
| | Humans | 26 | 2023 | 114049 | 0.190 |
Why?
| | Heparin | 1 | 2002 | 225 | 0.180 |
Why?
| | Thrombocytopenia | 1 | 2002 | 177 | 0.180 |
Why?
| | Interleukin-6 | 3 | 2023 | 673 | 0.180 |
Why?
| | Symptom Assessment | 1 | 2021 | 119 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 71 | 0.170 |
Why?
| | Antihypertensive Agents | 1 | 2003 | 428 | 0.160 |
Why?
| | alpha 1-Antitrypsin | 1 | 2020 | 102 | 0.160 |
Why?
| | Arthritis, Rheumatoid | 1 | 2007 | 1002 | 0.160 |
Why?
| | Vasoconstriction | 1 | 2020 | 177 | 0.160 |
Why?
| | Lung Diseases | 1 | 2005 | 690 | 0.160 |
Why?
| | Anticoagulants | 1 | 2002 | 547 | 0.150 |
Why?
| | Schistosoma | 1 | 2017 | 18 | 0.140 |
Why?
| | Female | 14 | 2021 | 59326 | 0.140 |
Why?
| | Curriculum | 1 | 2023 | 813 | 0.140 |
Why?
| | Genotype | 2 | 2023 | 1757 | 0.140 |
Why?
| | Myosin-Light-Chain Kinase | 2 | 2007 | 19 | 0.140 |
Why?
| | Platelet Count | 1 | 2016 | 79 | 0.130 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 266 | 0.130 |
Why?
| | Platelet Aggregation | 1 | 2016 | 90 | 0.130 |
Why?
| | Alternative Splicing | 1 | 2017 | 186 | 0.120 |
Why?
| | Adult | 8 | 2021 | 30377 | 0.120 |
Why?
| | Muscle, Skeletal | 1 | 2004 | 1468 | 0.120 |
Why?
| | Introns | 3 | 2011 | 227 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2017 | 590 | 0.120 |
Why?
| | Cannabis | 1 | 2021 | 383 | 0.120 |
Why?
| | Interleukin-8 | 1 | 2015 | 229 | 0.120 |
Why?
| | Case-Control Studies | 4 | 2016 | 3003 | 0.110 |
Why?
| | Macrophages | 1 | 2020 | 1259 | 0.110 |
Why?
| | Models, Biological | 1 | 2020 | 1611 | 0.110 |
Why?
| | Asthma | 2 | 2021 | 2021 | 0.100 |
Why?
| | Cell Line | 2 | 2015 | 2629 | 0.100 |
Why?
| | Sp1 Transcription Factor | 1 | 2011 | 23 | 0.100 |
Why?
| | Cell Growth Processes | 1 | 2011 | 51 | 0.100 |
Why?
| | Middle Aged | 9 | 2017 | 26607 | 0.090 |
Why?
| | Conserved Sequence | 1 | 2011 | 218 | 0.090 |
Why?
| | Interleukin-1 | 1 | 2015 | 965 | 0.090 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2011 | 191 | 0.090 |
Why?
| | Polymorphism, Genetic | 2 | 2011 | 610 | 0.090 |
Why?
| | Haplotypes | 3 | 2007 | 448 | 0.090 |
Why?
| | RNA Splicing | 1 | 2011 | 244 | 0.090 |
Why?
| | Respiration, Artificial | 2 | 2011 | 528 | 0.090 |
Why?
| | Male | 10 | 2017 | 55398 | 0.090 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2011 | 236 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 367 | 0.080 |
Why?
| | Toll-Like Receptor 1 | 1 | 2008 | 11 | 0.080 |
Why?
| | Binding Sites | 1 | 2011 | 1166 | 0.080 |
Why?
| | Macrophage Migration-Inhibitory Factors | 1 | 2007 | 10 | 0.070 |
Why?
| | B-Lymphocytes | 2 | 2022 | 762 | 0.070 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2007 | 57 | 0.070 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 225 | 0.070 |
Why?
| | Protein Binding | 1 | 2011 | 1888 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1024 | 0.060 |
Why?
| | Atmospheric Pressure | 1 | 2005 | 18 | 0.060 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1176 | 0.060 |
Why?
| | Linkage Disequilibrium | 1 | 2006 | 245 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1311 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 1 | 2006 | 228 | 0.060 |
Why?
| | Wounds and Injuries | 1 | 2012 | 674 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2011 | 3861 | 0.060 |
Why?
| | Transcription Factors | 1 | 2011 | 1526 | 0.060 |
Why?
| | Multigene Family | 1 | 2004 | 190 | 0.050 |
Why?
| | Xanthine Dehydrogenase | 1 | 2023 | 25 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 388 | 0.050 |
Why?
| | Uterus | 1 | 2004 | 191 | 0.050 |
Why?
| | Sildenafil Citrate | 1 | 2003 | 57 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2008 | 720 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 27 | 0.050 |
Why?
| | Hirudin Therapy | 1 | 2002 | 2 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 4680 | 0.050 |
Why?
| | Sulfones | 1 | 2003 | 97 | 0.050 |
Why?
| | Epoprostenol | 1 | 2003 | 133 | 0.050 |
Why?
| | NF-kappa B | 1 | 2006 | 636 | 0.050 |
Why?
| | Cohort Studies | 1 | 2011 | 4883 | 0.050 |
Why?
| | Purines | 1 | 2003 | 158 | 0.050 |
Why?
| | Inflammation | 2 | 2022 | 2464 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2005 | 484 | 0.050 |
Why?
| | Interferons | 1 | 2022 | 151 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2002 | 249 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2003 | 302 | 0.050 |
Why?
| | Antibody Formation | 1 | 2002 | 266 | 0.050 |
Why?
| | Animals | 5 | 2020 | 31565 | 0.040 |
Why?
| | Parabiosis | 1 | 2020 | 12 | 0.040 |
Why?
| | Virus Internalization | 1 | 2020 | 40 | 0.040 |
Why?
| | Piperazines | 1 | 2003 | 310 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 49 | 0.040 |
Why?
| | Leukocyte Elastase | 1 | 2020 | 71 | 0.040 |
Why?
| | Extracellular Traps | 1 | 2020 | 40 | 0.040 |
Why?
| | Serine Endopeptidases | 1 | 2020 | 101 | 0.040 |
Why?
| | Echocardiography | 1 | 2003 | 569 | 0.040 |
Why?
| | rho-Associated Kinases | 1 | 2020 | 80 | 0.040 |
Why?
| | RNA, Viral | 1 | 2023 | 565 | 0.040 |
Why?
| | Biomarkers | 2 | 2007 | 3397 | 0.040 |
Why?
| | Sulfonamides | 1 | 2003 | 444 | 0.040 |
Why?
| | Gene Expression | 1 | 2004 | 1417 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2003 | 545 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1228 | 0.040 |
Why?
| | Risk Factors | 3 | 2007 | 8614 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 520 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2003 | 926 | 0.040 |
Why?
| | Antigens, Ly | 1 | 2017 | 45 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 445 | 0.040 |
Why?
| | Signal Transduction | 2 | 2020 | 4501 | 0.030 |
Why?
| | Th2 Cells | 1 | 2017 | 154 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 9049 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 907 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3498 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 642 | 0.030 |
Why?
| | Exons | 2 | 2006 | 301 | 0.030 |
Why?
| | Autoantibodies | 1 | 2022 | 1347 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 918 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 2562 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 503 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1531 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2007 | 580 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1311 | 0.030 |
Why?
| | Apoptosis | 1 | 2020 | 2349 | 0.020 |
Why?
| | APACHE | 1 | 2011 | 58 | 0.020 |
Why?
| | Pedigree | 1 | 2012 | 460 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 384 | 0.020 |
Why?
| | Body Height | 1 | 2011 | 180 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 492 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2550 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 951 | 0.020 |
Why?
| | Prospective Studies | 2 | 2011 | 6195 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2008 | 36 | 0.020 |
Why?
| | Caribbean Region | 1 | 2007 | 19 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 1829 | 0.020 |
Why?
| | Sex Factors | 1 | 2011 | 1706 | 0.020 |
Why?
| | Thymine | 1 | 2006 | 12 | 0.020 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2006 | 20 | 0.020 |
Why?
| | Cytosine | 1 | 2006 | 43 | 0.020 |
Why?
| | Translocation, Genetic | 1 | 2006 | 92 | 0.020 |
Why?
| | Homozygote | 1 | 2006 | 187 | 0.020 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2004 | 6 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2006 | 337 | 0.010 |
Why?
| | Shock, Septic | 1 | 2006 | 185 | 0.010 |
Why?
| | Cause of Death | 1 | 2006 | 362 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 631 | 0.010 |
Why?
| | Dogs | 1 | 2004 | 331 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 739 | 0.010 |
Why?
| | Risk | 1 | 2006 | 810 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2006 | 552 | 0.010 |
Why?
| | Inflammation Mediators | 1 | 2006 | 475 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2322 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2006 | 813 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 742 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2004 | 990 | 0.010 |
Why?
| | Neutrophils | 1 | 2006 | 1089 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1310 | 0.010 |
Why?
| | Mice | 2 | 2007 | 14843 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2004 | 1791 | 0.010 |
Why?
| | Aged | 2 | 2007 | 18971 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2004 | 1518 | 0.010 |
Why?
| | Adolescent | 2 | 2006 | 17802 | 0.010 |
Why?
|
|
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|